No Data
H.C. Wainwright Maintains Kezar Life Sciences(KZR.US) With Hold Rating
HC Wainwright & Co. Reiterates Neutral on Kezar Life Sciencesto Neutral
KEZAR MARKETS ANNOUNCES RETIREMENT OF CEO WHIT CONARY & NAMES STEVE MIELE AS THE NEW CHIEF EXECUTIVE OFFICER
Express News | Kezar Life Sciences Inc: On November 13, Regains Compliance With Nasdaq’s Minimum Bid Price Requirement
Kezar Life Sciences Is Maintained at Equal-Weight by Wells Fargo
Wells Fargo Maintains Kezar Life Sciences(KZR.US) With Hold Rating, Cuts Target Price to $11
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
